In a statement on Wednesday, Mainz-based BioNTech said it signed a definitive agreement to pay mostly cash for 100 per cent ...

For example, their much smaller peer, Mainz Biomed (NASDAQ: MYNZ) just announced a new collaboration agreement aimed at ...

The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...

Germany pharmaceutical company BioNTech, which shot to global prominence after its early coronavirus vaccine, has boosted its ...

Sport Bild (via @bvbnewsblog) reports that Borussia Dortmund head coach Nuri Şahin maintains the support of the club’s bosses ...

Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational PD-L1 x VEGF-A bispecific antibody, with potential to ...